Skip to main content
Caplight Logo









1849 bio

1849 bio

Private
San Francisco, CaliforniaFrontier & Industrial Techhttps://1849.bio

Last Round

Seed

Sep 1, 2024

Total Funding Raised

$500,000

Company Overview

1849 bio operates in Frontier & Industrial Tech and is based in San Francisco, California. Its latest recorded funding round was a Seed round in September 2024.

1849 bio is a biotechnology company that develops engineered microbes to enable sustainable and cost-effective metal extraction from low-quality and waste ores.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Circular Economy, Waste Management

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

1849 bio Comparables

Compare 1849 bio with similar companies based on industry and business-model similarity.

1849 bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Giraffe Bio
88%
EcoBiome Metals
88%
Cyclobiome
86%
Book a demo to see all comparables

For institutional investors. Book with your work email.

1849 bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 1, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

1849 bio Investors

Notable investors and investment history

1849 bio investors
InvestorRounds
D3 Jubilee PartnersSeed
Batch VenturesSeed
SBXiSeed
FuturePlaySeed
Y CombinatorSeed
Soma CapitalSeed
Positive VenturesSeed
Book a demo to see all 10 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 15, 2024

    $500K round led by Y Combinator

Book a demo to see all signals

For institutional investors. Book with your work email.

1849 bio Filings

Explore SEC and related filing metadata, where available.

1849 bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about 1849 bio's valuation, stock price, and market status.

Is 1849 bio a public or private company?

1849 bio is a private company.

What is the current stock price of 1849 bio?

1849 bio is a private company, so its shares have no public market price. Caplight tracks 1849 bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is 1849 bio worth (valuation)?

Valuation information for 1849 bio is not publicly available.

Can I buy 1849 bio stock?

1849 bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was 1849 bio's last funding round?

1849 bio's most recent funding round was Seed on September 1, 2024.

Who are the main investors in 1849 bio?

Key investors in 1849 bio include Y Combinator.

Will 1849 bio IPO soon?

No public IPO plans have been announced for 1849 bio.

How can I track 1849 bio secondary market activity?

Caplight tracks bids, offers, and trades in 1849 bio's shares on secondary markets.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range3
Year Founded2024
Last FundingSep 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?